Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Clinical trial NCT06805812 · RECRUITING

Trial details

NCT number: NCT06805812
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Adenocarcinoma Breast Cancer Stage IV Breast Cancer, Metastatic Breast Carcinoma Breast Diseases Breast Neoplasms Breast Neoplasms, Male Breast Cancer Breast Cancer With Metastatic Bone Disease Breast Cancers Breast Neoplasm Breast Tumors

Start date: 2023-05-01
Primary completion: 2030-12-31
Enrollment: 3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.